(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and CEO, will provide an update on the Company and the commercial launch of Feraheme® (ferumoxytol) Injection for intravenous (IV) use, at the 29th Annual J.P. Morgan Healthcare Conference on January 10, 2011 at 2:30 p.m. Pacific time.
